I don't think anyone should be surprised at the selling. Despite what we know to be true, the third change in the dividend date and the reneging of a partner reminds everyone of old mgmt. It isn't fair, but that's the way it is.
It is going to take something very significant to turn sentiment around. Indeed we are at the mercy of the company. The goodies bag is empty, once the NGIO shares are assessed and become public. All that's left is execution and a lot of it.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links